Fulcrum Therapeutics Inc (FULC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 4,789 | 4,225 | 1,848 | 2,000 | 750 |
| Gross Profit | 4,789 | 4,225 | 1,848 | 2,000 | 750 |
| Operating Expenses | 21,832 | 22,012 | 20,952 | 17,924 | 19,546 |
| Operating Income | -17,043 | -17,787 | -19,104 | -15,924 | -18,796 |
| Other Income | 44 | 67 | 142 | 239 | 344 |
| Pre-tax Income | -16,999 | -17,720 | -18,962 | -15,685 | -18,452 |
| Net Income Continuous | -16,999 | -17,720 | -18,962 | -15,685 | -18,452 |
| Net Income | $-16,999 | $-17,720 | $-18,962 | $-15,685 | $-18,452 |
| EPS Basic Total Ops | -0.54 | -0.62 | -0.70 | -0.66 | -0.81 |
| EPS Basic Continuous Ops | -0.54 | -0.63 | -0.70 | -0.66 | -0.81 |
| EPS Diluted Total Ops | -0.54 | -0.62 | -0.70 | -0.66 | -0.81 |
| EPS Diluted Continuous Ops | -0.54 | -0.63 | -0.70 | -0.66 | -0.81 |
| EBITDA(a) | $-16,440 | $-17,054 | $-18,550 | $-15,371 | $-18,257 |